Summary of VIP5 Dosing Protocol
Vasoactive Intestinal Peptide (VIP)‑5 is a biologically active peptide administered for immune, inflammatory, and systemic regulatory support. VIP functions as a neuropeptide with broad physiological roles including vasodilation, anti‑inflammatory modulation, and immune regulation (Strive Pharmacy, 2025; Restorative Compounding, 2025). The VIP5 dosing protocol typically involves subcutaneous injections of 0.2 mg (20 units) administered five times per week. A standard vial contains 5 mg of VIP reconstituted with bacteriostatic water at a concentration of 1 mg/mL, yielding approximately 25 doses per vial (extension.health, 2025). The protocol often recommends three months of continuous use followed by one month off, repeated annually for three cycles to optimize therapeutic outcomes and minimize tolerance (extension.health, 2025). Injections are given in subcutaneous fat (e.g., abdomen or thigh) and can be scheduled at a consistent time of day to align with circadian regulation. Common adverse effects include mild local reactions, headaches, nausea, or flushing; rotation of injection sites and hydration may reduce side effects (extension.health, 2025). VIP dosing should be prescribed and monitored by a qualified clinician.
Dosing Chart
| Week | Days (M–F) | Dose per Injection | Total Weekly Dose |
|---|---|---|---|
| 1–12 | Mon–Fri | 0.2 mg (20 units) | 1.0 mg |
| Cycle | 3 months on / 1 month off | — | — |
References
extension.health. (2025). VIP (5 mg) injectable peptide patient information (VIP5 mg).
Strive Pharmacy. (2025). Vasoactive Intestinal Peptide (VIP) dosage guide.
(Restorative Compounding, 2025)
